Tobacco Use in Patients With HPV-positive Head and Neck Cancer Worsens Outcome

Researchers at University of Michigan Comprehensive Cancer Center claim that patients have worse outcomes if they are current or former tobacco users, with head and neck cancer

Researchers at University of Michigan Comprehensive Cancer Center claim that patients have worse outcomes if they are current or former tobacco users, with head and neck cancer linked to high risk human papillomavirus or HPV.

High-risk HPVs are the same viruses that are associated with cancers of the uterine cervix.

Chemoradiation With Paclitaxel Combo may Help to Treat Neck, Head Cancers
A new study has shown that chemoradiation therapy along with generic drug Paclitaxel may be helpful for treating neck and head cancers.

The research suggests that current or former tobacco users may need a more aggressive treatment regimen than patients who have never used tobacco.

In the new study, boffins found that current tobacco users with HPV-positive tumors were five times more likely to have their cancer recur. Even former smokers had an increased risk of recurrence.

"Because the effect of HPV is so strong in giving a very good prognostic picture, we were surprised to find that smoking remained a huge issue, and it actually affected the outcome in patients who smoked," says senior study author Thomas Carey, Ph.D., professor of otolaryngology and pharmacology, and co-director of the Head and Neck Oncology Program at the U-M Comprehensive Cancer Center.

Boron Neutron Capture Therapy (BNCT) a New Treatment for Neck and Head Cancer
A new radiation therapy has been developed where large dose of radiation can be aimed to cancer using a well-tolerated boron compound

Results of the study appear in the Feb. 15 issue of Clinical Cancer Research.

The study looked at 124 patients with advanced oropharyngeal cancer, which is cancer of the tonsils or the base of the tongue. Most of these patients had HPV DNA in their tumors, which is consistent with HPV being a major factor in oropharyngeal cancer development. All 22 of the HPV-negative patients were tobacco users, and about two-thirds of the 102 HPV-positive patients were current or former tobacco users.

More Stress, More Cancer
More stress can lead to the growth and spread of cancer and controlling stress might help to control it, says a recent research finding.

Of the HPV-positive patients who had never used tobacco, 6 percent had a recurrence of their cancer. Meanwhile, 19 percent of former tobacco users and 35 percent of current tobacco users ad a recurrence. Still, the outcomes were better than the HPV-negative patients, all of whom were smokers, and among whom half recurred.

Source-ANI
TRI